Hi @jamesmurray_ldn, I'm your constituent, horrified by the killing of thousands of civilians in Gaza. As the death toll continues to rise, we urgently need a ceasefire. Will you back the amendment? #CeasefireNow
1
159
Pash retweeted
With 250+ staff in two countries, and brand new production capabilities at our disposal, we're excited to launch our VISITECT®️ COVID-19 Antigen test, providing healthcare professionals with an accurate rapid test for the detection of #COVID19.
🎥 Here's a sneak peek…
Pash retweeted
Good news, all resolutions were passed at today’s #ORPH General Meeting.
Further announcements regarding the proposed Distribution in Specie will be made in due course.
londonstockexchange.com/news…
Pash retweeted
“...The Disease in Motion platform includes data from cutting edge wearables that are applicable to a wide variety of end users including big tech, wearables, pharma and biotech companies...”
Cathal Friel, #ORPH Executive Chairman
londonstockexchange.com/news…
Pash retweeted
“Takes a look at today's papers”...👀
@thetimes: Rapid Lateral Flow Tests
@telegraph: Rapid Lateral Flow Tests
@guardian: Rapid Lateral Flow Tests
@thesun: Rapid Lateral Flow Tests
@dailymailuk: Rapid Lateral Flow Tests
🙌 #ODX
Pash retweeted
A Q&A with Colin King, CEO of Omega Diagnostics (AIM: #ODX, @OmegaDiagnostic), is covered today by @sharebuyers; sharebuyers.co.uk/shares/col…
Pash retweeted
Our London operation @hVIVO_UK has signed another substantial RSV human challenge study contract with a US biotech firm.
This £7.5m study will commence in Q4 2021 at our East London facilities with the majority of revenues being recognised in 2021
londonstockexchange.com/news…
Pash retweeted
In case you missed it.... #ODX
📈 Headcount at our Alva and @CamNutri sites is rapidly expanding as we scale-up.
An overview:
Mar 20
• 🏴: 71
• 🏴: 64
• Total: 135
Sep 20
• 🏴: 71
• 🏴: 73
• Total: 144
Jan 21
• 🏴: 121
• 🏴: 70
• Total: 191
Apr 21
• 250+
*BIG* things are happening…
#ODX
Pash retweeted
It’s worth pointing out that even after *considerable* investment in our scaled-up production capacity, year-end (i.e. 31 March 2021) cash is expected to be in the region of £5.5-£6m.
📍 Let’s put those placing rumours to bed. For good.
#ODX | #InColinWeTrust
Pash retweeted
The supply of antigen tests under the @DHSCgovuk contract (plus the other tests above) is expected to have *significant* impact on future performance.
📈 Although volumes are unquantified, we expect substantial revenue growth in the new financial year.
#COVID19 | #ODX
Pash retweeted
✍️ We're delighted to announce that UK Government has valued our 11 February contract, to provide manufacturing capacity for #COVID19 Lateral Flow Antigen Tests, at £374 million.
📃 A UK Public Sector disclosure was published today by @DHSCgovuk.
#ODX | THREAD
Pash retweeted
Accurate.
Reliable.
To be made in Alva.
By us.
#ODX
New analysis reinforces that lateral flow #COVID19 tests are accurate and reliable.
Results show there is less than one false positive for every 1,000 lateral flow tests carried out.
More: gov.uk/government/news/new-a…
Watch to find out more about how rapid testing works 👇
Pash retweeted
From today, businesses of all sizes can register to order Lateral Flow Tests (LFTs) for their staff, @DHSCgovuk has announced.
Workplace #COVID19 testing is now available to *all* businesses in England.
#ODX | THREAD ⤵️
Pash retweeted
📈 Headcount at our Alva and @CamNutri sites is rapidly expanding as we scale-up.
An overview:
Mar 20
• 🏴: 71
• 🏴: 64
• Total: 135
Sep 20
• 🏴: 71
• 🏴: 73
• Total: 144
Jan 21
• 🏴: 121
• 🏴: 70
• Total: 191
Apr 21
• 250+
*BIG* things are happening…
#ODX
Pash retweeted
Working with @Screen4Org, we've created and validated a home-collection IgG Finger Prick Antibody Test.
Distributed by Screen4, and approved for Home Use, the 'self-collect test' is posted back to our Cambridgeshire lab for analysis.
#ODX
screen4.org/product/finger-p…













